Global Newcastle Disease Vaccine Competitive Landscape Professional Research Report 2024

Global Newcastle Disease Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

Newcastle Disease Vaccine is a type of vaccine used to protect poultry, particularly chickens, against Newcastle disease (ND), also known as avian paramyxovirus type 1. Newcastle disease is a highly contagious viral infection that affects birds, causing respiratory, nervous system, and gastrointestinal symptoms. The vaccine is developed using live or inactivated strains of Newcastle disease virus and is administered to chickens via various routes, such as drinking water, spray, or eye drops. The vaccine stimulates the bird’s immune system to produce antibodies against the virus, providing protection and reducing the severity of the disease if the bird is exposed to the ND virus in the future. Newcastle Disease Vaccine plays a crucial role in preventing Newcastle disease outbreaks, ensuring the health and productivity of poultry flocks, and safeguarding the poultry industry.

According to DIResearch's in-depth investigation and research, the global Newcastle Disease Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, Zoetis, DHN, Elanco (Lohmann), ChengDu Tecbond, FATRO, CAVAC, Vaksindo etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Newcastle Disease Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Newcastle Disease Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Newcastle Disease Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Newcastle Disease Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Newcastle Disease Vaccine Include:

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

Zoetis

DHN

Elanco (Lohmann)

ChengDu Tecbond

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Product Segment Include:

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Product Application Include:

Chicken

Duck & Goose

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Newcastle Disease Vaccine Industry PESTEL Analysis

Chapter 3: Global Newcastle Disease Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Newcastle Disease Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Newcastle Disease Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Newcastle Disease Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources